In protocol two, to address the role of mTOR in chronic/established allergic asthma, mice were exposed to HDM for 6 weeks and treated with rapamycin or dexamethasone from weeks 4 to 6 of the exposure period. This evidence concerns the gene MTOR and allergic asthma.